Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

614.38
Delayed Data
As of Jan 20
 -3.73 / -0.60%
Today’s Change
441.00
Today|||52-Week Range
686.62
-2.71%
Year-to-Date

Today’s Trading

Previous close618.11
Today’s open622.68
Day’s range612.50 - 622.69
Volume39,103
Average volume (3 months)755,494
Market cap$66.2B
Data as of 4:00pm ET, 01/20/2022

Growth & Valuation

Earnings growth (last year)+68.51%
Earnings growth (this year)+123.78%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)+8.06%
P/E ratio9.8
Price/Sales6.54
Price/Book5.97

Competitors

----
VRTXVertex Pharmaceutica...-2.23-0.97%
----
----
Data as of 4:05pm ET, 01/20/2022

Financials

Next reporting dateFebruary 4, 2022
EPS forecast (this quarter)$19.68
Annual revenue (last year)$8.5B
Annual profit (last year)$3.5B
Net profit margin41.35%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Tarrytown, New York

Forecasts